{"podcast":{"title":"US News Today | 2 Min News | The Daily News Now!","slug":"us-news-today-2-min-news-the-daily-news-now-7023297","podcast_index_feed_id":7023297,"rss_url":"https://feeds.fastcast.ai/who-the-is-chuck-taylor.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/who-the-is-chuck-taylor.jpg","author":"The Daily News Now!","episode_count":1314,"summary":"Hosted by Corey with the Story, US News Today delivers daily coverage of the biggest stories shaping the United States with fast, focused updates on national news, politics, business, economy, public safety, and cultural moments. From breaking headlines to ongoing national developments, the show keeps you informed on what matters most across the country. Each short episode highlights what matters most—including key updates, national trends, and major storylines—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, US News Today is built for listeners who want reliable national news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-20T06:20:39.345774+00:00","page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297"},"episode":{"title":"FDA Approves First PCSK9 Pill for Cholesterol | US News","slug":"fda-approves-first-pcsk9-pill-for-cholesterol-us-news","published_at":"2026-07-17T01:36:11+00:00","page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/fda-approves-first-pcsk9-pill-for-cholesterol-us-news","show_page_url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297","url":"https://sources.thednn.ai/c5d1e2e8803016a5","audio_url":"https://api.fastcast.ai/audio/f453d200-7636-495f-9399-6f0f51d5136c.mp3","summary":"FDA just approved Lipfendra, the first daily pill targeting PCSK9 to slash bad cholesterol—offering a cheaper, no-shot alternative to pricey injectables. At $315/month, it’s a game-changer for adults on max statins, slashing LDL by 56-59% in trials. Cardiologists are thrilled: this could make cholesterol control as routine as a daily statin, empowering primary care doctors and helping meet new heart attack/stroke prevention goals. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/c5d1e2e8803016a5","meta_description":"FDA just approved Lipfendra, the first daily pill targeting PCSK9 to slash bad cholesterol—offering a cheaper, no-shot alternative to pricey injectables.…","key_points":[],"chapters":[],"topics":[],"duration_seconds":120,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/us-news-today-2-min-news-the-daily-news-now-7023297/episodes/fda-approves-first-pcsk9-pill-for-cholesterol-us-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/us-news-today-2-min-news-the-daily-news-now-7023297/fda-approves-first-pcsk9-pill-for-cholesterol-us-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}